HHS Plans New FDA Deputy Commissioners for Tech and Drugs

The U.S. Department of Health and Human Services plans to appoint two new deputy commissioners to the Food and Drug Administration. One appointee will oversee drug regulation, while the second will focus on healthcare technology and artificial intelligence. Jared Seehafer has emerged as the leading candidate for the technology-focused role, although the agency has not yet formally announced the appointments or finalized the decisions.

These planned appointments follow the recent nomination of White House policy aide Heidi Overton to lead the FDA. President Donald Trump named Overton to the top position, and her selection currently awaits confirmation by the U.S. Senate.